Pieris Pharmaceuticals Inc (PIRS)

[INFINITI]

Pieris: Shares Can Still Soar Much Higher, Says Analyst

Source: TipRanks
There’s nothing like a slice of good news to send the stock of a micro-cap biotech on an almighty tear. On Tuesday, the blueprint was followed to a tee. Shares of Pieris Pharmaceuticals (PIRS) more than doubled in the session after it was announced that the Boston-based company had nabbed a deal that could generate it a lot of money. Specifically, the company said it was forming a partnership with Roche subsidiary Genentech to collaborate on the development of respiratory and ophthalmology therapies based on Pieris' Anticalin technology. Pieris will secure an upfront payment of $20 million and will be entitled to over $1.
https://www.tipranks.com/news/article/pieris-shares-can-still-soar-much-higher-says-analyst